Abstract

SARS-CoV-2 and influenza are the main respiratory viruses for which effective vaccines are currently available. Strategies in which COVID-19 and influenza vaccines are administered simultaneously or combined into a single preparation are advantageous and may increase vaccination uptake. Here, we comprehensively review the available evidence on COVID-19/influenza vaccine co-administration and combination vaccine candidates from the standpoints of safety, immunogenicity, efficacy, policy and public acceptance. While several observational studies have shown that the trained immunity induced by influenza vaccines can protect against some COVID-19-related endpoints, it is not yet understood whether co-administration or combination vaccines can exert additive effects on relevant outcomes. In randomized controlled trials, co-administration has proved safe, with a reactogenicity profile similar to that of either vaccine administered alone. From the immunogenicity standpoint, the immune response towards four influenza strains and the SARS-CoV-2 spike protein in co-administration groups is generally non-inferior to that seen in groups receiving either vaccine alone. Several public health authorities have advocated co-administration. Different combination vaccine candidates are in (pre)-clinical development. The hesitancy towards vaccine co-administration or combination vaccines is a multifaceted phenomenon and may be higher than the acceptance of either vaccine administered separately. Public health implications are discussed.

MeSH

Vaccines, Cross Protection, Vaccination, Covid-19, Influenza, Human, Immunity, Influenza Vaccines, Vaccines, Combined

Cited by

• Real-life experience on COVID-19 and seasonal influenza vaccines co-administration in the vaccination hub of the University Hospital of Palermo, Italy. Hum Vaccin Immunother, 2024
• Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies. Hum Vaccin Immunother, 2022
• The Importance of COVID-19/Influenza Vaccines Co-Administration: An Essential Public Health Tool. Infect Dis Rep, 2022
• Socio-demographic determinants of influenza vaccination uptake behavior: A nationwide cross-sectional study in Saudi Arabia. Saudi Med J, 2023
• Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question. Hum Vaccin Immunother, 2022
• Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study. Eur J Public Health, 2023
• Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis. Vaccines (Basel), 2023
• Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis. Front Immunol, 2024
• The impact of seasonal influenza vaccination uptake on COVID-19 vaccination attitudes in a rural area in Greece. Vaccine, 2023
• Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact. Vaccine, 2024
• Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly. Hum Vaccin Immunother, 2024
• Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital. Vaccines (Basel), 2022
• Biometric Strategies to Improve Vaccine Immunogenicity and Effectiveness. Biomimetics (Basel), 2025
• Active Surveillance for Safety Monitoring of XBB.1.5-Containing COVID-19 mRNA Vaccines in Korea. J Korean Med Sci, 2024
• Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity. Vaccine, 2023
• The underlying mechanism behind the different outcomes of COVID-19 in children and adults. Front Immunol, 2025
• The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review. Infect Dis Ther, 2025
• Adherence to Herpes Zoster (Shingles) Catch-Up Campaign at the Romagna Local Health Authority (Italy), a Multi-Center Retrospective Observational Study. Vaccines (Basel), 2022
• Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine. JAMA Netw Open, 2023
• Willingness among adults in the United States to receive a combination influenza and COVID-19 vaccine. Hum Vaccin Immunother, 2025